1 |
(minus)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate |
- |
- |
- |
- |
006 [1] 6 💬 |
2 |
10 mg natura-alpha capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
3 |
100 µg brimonidine tartrate implant |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
4 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
5 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
6 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
7 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
8 |
2 x 10 mg natura-alpha capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
9 |
2% chlorhexidine solution wipes |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
10 |
200 µg brimonidine tartrate implant |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
11 |
3-(3,4-dihydroxyphenyl)-l-alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [1] 6 💬 |
12 |
3h-cholesterol bound to albumin |
Cholesterol |
[1] D00040 D00040 💬 |
- |
- |
259 [2] 259, 261 💬 |
13 |
4% chlorhexidine gluconate liquid skin cleanser |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
14 |
400 µg brimonidine tartrate implant |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
15 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
[11] D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 [7] ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 [1] 226 💬 |
16 |
6 alpha-ethylchenodeoxycholic acid (6-edca), oca, int-747 |
- |
- |
- |
- |
093 [1] 93 💬 |
17 |
89 zirconium recombinant human alpha-n-acetylglucosaminidase (rhnaglu) (radiolabeled) |
- |
- |
- |
- |
019 [1] 19 💬 |
18 |
90 mg hydrocortisone acetate suppository with sephure suppository applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
19 |
98% dehydrated alcohol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 [1] 298 💬 |
20 |
[allo-apz2-eb] |
- |
- |
- |
- |
036 [1] 36 💬 |
21 |
Abi-009, nab-rapamycin, albumin-bound rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
086 [1] 86 💬 |
22 |
Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
086 [1] 86 💬 |
23 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
24 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
25 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
26 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
27 |
Adeno-associated viral vector serotype 9 containing the human n-acetyl-alpha-glucosaminidase gene |
- |
- |
- |
- |
019 [1] 19 💬 |
28 |
Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
29 |
Aerosolized human alpha-1 antitrypsin |
- |
- |
- |
- |
231 [1] 231 💬 |
30 |
Aerosolized, human, plasma-derived alpha-1 antitrypsin |
- |
- |
- |
- |
299 [1] 299 💬 |
31 |
Agalsidase alfa |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
32 |
Agalsidase alpha |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
33 |
Al |
- |
- |
- |
- |
005 [9] 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
34 |
Al-108 |
- |
- |
- |
- |
005 [1] 5 💬 |
35 |
Al001 |
- |
- |
- |
- |
127 [1] 127 💬 |
36 |
Ala |
- |
- |
- |
- |
286 [1] 286 💬 |
37 |
Alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [4] 6 , 13, 298, 299 💬 |
38 |
Albendazole |
Albendazole |
[1] D00134 D00134 💬 |
- |
- |
096 [1] 96 💬 |
39 |
Albendazole (eskazole) |
Albendazole |
[1] D00134 D00134 💬 |
- |
- |
096 [1] 96 💬 |
40 |
Albumen |
Egg white |
- |
- |
- |
096 [1] 96 💬 |
41 |
Albumin |
- |
- |
- |
- |
002 [3] 2 , 20, 51 💬 |
42 |
Albumin (human) 20%, united states pharmacopeia (usp) |
- |
- |
- |
- |
231 [1] 231 💬 |
43 |
Albumin (human) 25%, united states pharmacopeia (usp) |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
44 |
Albumin solution |
- |
- |
- |
- |
020 [1] 20 💬 |
45 |
Albumine humaine |
- |
- |
- |
- |
096 [1] 96 💬 |
46 |
Albunorm® 5%, |
- |
- |
- |
- |
020 [1] 20 💬 |
47 |
Albutein 5% |
- |
- |
- |
- |
002 [1] 2 💬 |
48 |
Albuterol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 [8] 12, 13, 86, 89, 113, 231, 256, 299 💬 |
49 |
Albuterol first |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
50 |
Albuterol inhaler |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
089 [1] 89 💬 |
51 |
Albuterol inhaler. |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
231 [2] 231, 299 💬 |
52 |
Albuterol nebulizer |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
089 [1] 89 💬 |
53 |
Albuterol. |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
54 |
Albutropin |
- |
- |
- |
- |
078 [1] 78 💬 |
55 |
Albúmina humana |
- |
- |
- |
- |
002 [1] 2 💬 |
56 |
Alcohol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 [4] 13, 58, 279, 298 💬 |
57 |
Ald518 |
- |
- |
- |
- |
046 [1] 46 💬 |
58 |
Ald518 monoclonal antibody (anti il-6 mab) |
- |
- |
- |
- |
046 [1] 46 💬 |
59 |
Aldesleuchina |
- |
- |
- |
- |
049 [1] 49 💬 |
60 |
Aldesleukin |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [4] 49, 65, 96, 97 💬 |
61 |
Aldosterone |
Aldosterone |
[1] D10528 D10528 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
222 [1] 222 💬 |
62 |
Aldurazyme |
- |
- |
- |
- |
019 [1] 19 💬 |
63 |
Aldurazyme (laronidase) |
Laronidase |
[1] D04670 D04670 💬 |
IDUA [1] IDUA 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [2] 19, 256 💬 |
64 |
Aldurazyme (recombinant human alpha-l-iduronidase) |
- |
- |
- |
- |
019 [1] 19 💬 |
65 |
Aldurazyme*infus 1fl 5ml 500u |
- |
- |
- |
- |
019 [1] 19 💬 |
66 |
Alefacept |
Alefacept |
[1] D02800 D02800 💬 |
CD58 [1] CD58 💬 |
Cell adhesion molecules [2] Cell adhesion molecules, Epstein-Barr virus infection |
037 [6] 37, 60, 65, 164, 284, 285 💬 |
67 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
68 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
046 [1] 46 💬 |
69 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
046 [1] 46 💬 |
70 |
Alemtuzumab (campath ) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
060 [1] 60 💬 |
71 |
Alemtuzumab (campath) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
015 [1] 15 💬 |
72 |
Alemtuzumab (gz402673) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
73 |
Alemtuzumab 0.2 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
065 [2] 65, 164 💬 |
74 |
Alemtuzumab 0.3 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
065 [2] 65, 164 💬 |
75 |
Alemtuzumab 12 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
76 |
Alemtuzumab 24 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
77 |
Alemtuzumab and rituximab |
Alemtuzumab |
[2] D02802 D02802, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
060 [1] 60 💬 |
78 |
Alemtuzumab gz402673 |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
79 |
Alemtuzumab immunotherapy |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
80 |
Alemtuzumab injection |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
81 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
82 |
Alemtuzumab, rituximab |
Alemtuzumab |
[2] D02802 D02802, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
83 |
Alendronat teva |
- |
- |
- |
- |
046 [1] 46 💬 |
84 |
Alendronate |
Alendronic acid |
[2] D00939 D00939, D07119 D07119 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
019 [7] 19, 41, 46, 50, 271, 274, 299 💬 |
85 |
Alendronate sodium |
Alendronic acid |
[2] D00939 D00939, D07119 D07119 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
019 [2] 19, 299 💬 |
86 |
Alendronate versus alfacalcidol (1-alpha oh vitamin d) |
Alendronic acid |
[3] D00939 D00939, D01518 D01518, D07119 D07119 💬 |
FDPS [2] FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [8] Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
041 [3] 41, 46, 50 💬 |
87 |
Alendronic acid |
Alendronic acid |
[2] D00939 D00939, D07119 D07119 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [2] 46, 274 💬 |
88 |
Alentuzumab (campath) |
- |
- |
- |
- |
065 [1] 65 💬 |
89 |
Alequel |
- |
- |
- |
- |
096 [1] 96 💬 |
90 |
Alfa-manosidadas humana recombinante |
- |
- |
- |
- |
019 [1] 19 💬 |
91 |
Alfacalcidol |
Alfacalcidol |
[1] D01518 D01518 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 [6] 41, 46, 49, 50, 96, 235 💬 |
92 |
Alfacalcidol 2 micrograms/ml |
Alfacalcidol |
[1] D01518 D01518 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
050 [1] 50 💬 |
93 |
Alfuzosin |
Alfuzosin |
[2] D01692 D01692, D07124 D07124 💬 |
ADRA1A [1] ADRA1A 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
94 |
Alga dunaliella bardawil |
- |
- |
- |
- |
090 [1] 90 💬 |
95 |
Alga dunaliella bardawil powder |
- |
- |
- |
- |
090 [1] 90 💬 |
96 |
Alga dunaliella bardawill |
- |
- |
- |
- |
090 [1] 90 💬 |
97 |
Alginate |
Alginic acid |
[1] D02324 D02324 💬 |
- |
- |
053 [2] 53, 299 💬 |
98 |
Alginate oligosaccharide |
Alginic acid |
[1] D02324 D02324 💬 |
- |
- |
299 [1] 299 💬 |
99 |
Alginic acid |
Alginic acid |
[1] D02324 D02324 💬 |
- |
- |
051 [1] 51 💬 |
100 |
Alglucosidase alfa |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
101 |
Alglucosidase alfa (genetical recombination) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
102 |
Alglucosidase alfa (gz419829) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
103 |
Alglucosidase alfa (myozyme) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
104 |
Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhgaa]) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
105 |
Alglucosidase alfa gz419829 |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
106 |
Alglucosidase alpha |
- |
- |
- |
- |
256 [1] 256 💬 |
107 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 [2] 96, 97 💬 |
108 |
Alicalm (polymeric liquid formula) |
- |
- |
- |
- |
096 [1] 96 💬 |
109 |
Alirocumab |
Alirocumab |
[1] D10335 D10335 💬 |
PCSK9 [1] PCSK9 💬 |
Cholesterol metabolism [1] Cholesterol metabolism |
079 [1] 79 💬 |
110 |
Alirocumab sar236553 (regn727) |
Alirocumab |
[1] D10335 D10335 💬 |
PCSK9 [1] PCSK9 💬 |
Cholesterol metabolism [1] Cholesterol metabolism |
079 [1] 79 💬 |
111 |
Aliskiren |
Aliskiren |
[1] D03208 D03208 💬 |
REN [1] REN 💬 |
Diabetic cardiomyopathy [3] Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system |
066 [4] 66, 167, 222, 223 💬 |
112 |
Alitretinoin |
Alitretinoin |
[1] D02815 D02815 💬 |
RARA [5] RARA, RARB, RXRA, RXRB, RXRG 💬 |
Acute myeloid leukemia [17] Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
049 [1] 49 💬 |
113 |
Alk-001 |
- |
- |
- |
- |
301 [1] 301 💬 |
114 |
Alk-001 (no generic name) |
- |
- |
- |
- |
301 [1] 301 💬 |
115 |
Alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 [4] 46, 93, 97, 172 💬 |
116 |
Alkalinized lidocaine-heparin |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
117 |
Alkeran |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
118 |
Alks 8700 |
- |
- |
- |
- |
013 [1] 13 💬 |
119 |
Alks 8700 delayed release (dr) |
- |
- |
- |
- |
013 [1] 13 💬 |
120 |
Alks 8700 delayed release (dr) capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
121 |
All subjects will receive maraviroc 300mg orally twice a day for 6 weeks |
Maraviroc |
[1] D06670 D06670 💬 |
CCR5 [1] CCR5 💬 |
Chemokine signaling pathway [9] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
084 [1] 84 💬 |
122 |
All-trans retinoic acid |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
094 [1] 94 💬 |
123 |
All-trans retinoid acid(atra) |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
063 [1] 63 💬 |
124 |
Allantoin |
Allantoin |
[1] D00121 D00121 💬 |
- |
- |
036 [1] 36 💬 |
125 |
Allergen |
- |
- |
- |
- |
098 [1] 98 💬 |
126 |
Allergy immunotherapy (allergy shots) |
- |
- |
- |
- |
098 [1] 98 💬 |
127 |
Allo-apz2-eb |
- |
- |
- |
- |
036 [1] 36 💬 |
128 |
Allo-asc |
- |
- |
- |
- |
096 [1] 96 💬 |
129 |
Allo-asc-cd |
- |
- |
- |
- |
096 [1] 96 💬 |
130 |
Allo-asc-dfu |
- |
- |
- |
- |
036 [1] 36 💬 |
131 |
Allo-hmscs |
- |
- |
- |
- |
211 [2] 211, 299 💬 |
132 |
Allogen-li |
- |
- |
- |
- |
070 [1] 70 💬 |
133 |
Allogeneic adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 [1] 97 💬 |
134 |
Allogeneic adipose tissue-derived mesenchymal stem cells expanded |
- |
- |
- |
- |
053 [1] 53 💬 |
135 |
Allogeneic adipose tissue-derived stromal/stem cells |
- |
- |
- |
- |
053 [1] 53 💬 |
136 |
Allogeneic adult human mesenchymal stem cells (hmscs) |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
085 [1] 85 💬 |
137 |
Allogeneic bone marrow derived human mesenchymal stem cells (hmscs) |
- |
- |
- |
- |
096 [1] 96 💬 |
138 |
Allogeneic bone marrow transplant |
- |
- |
- |
- |
049 [1] 49 💬 |
139 |
Allogeneic bone marrow-derived mscs (1 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
140 |
Allogeneic bone marrow-derived mscs (10 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
141 |
Allogeneic bone marrow-derived mscs (3 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
142 |
Allogeneic bone marrow-derived mscs (6 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
143 |
Allogeneic cardiosphere-derived cells (cap-1002) |
CAP-1002 |
- |
- |
- |
113 [1] 113 💬 |
144 |
Allogeneic donor derived b-lymphocytes |
- |
- |
- |
- |
060 [1] 60 💬 |
145 |
Allogeneic fecal microbiota |
- |
- |
- |
- |
013 [1] 13 💬 |
146 |
Allogeneic human cardiosphere-derived stem cells |
- |
- |
- |
- |
086 [1] 86 💬 |
147 |
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
148 |
Allogeneic mesenchymal precursor cells |
- |
- |
- |
- |
046 [1] 46 💬 |
149 |
Allogeneic mesenchymal stem cells |
- |
- |
- |
- |
047 [1] 47 💬 |
150 |
Allogeneic mesenchymal stem cells (allomsc) |
- |
- |
- |
- |
051 [2] 51, 53 💬 |
151 |
Allogeneic mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
036 [1] 36 💬 |
152 |
Allogeneic mesenchymal stromal cells derived from the umbilical cord |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
049 [1] 49 💬 |
153 |
Allogeneic msc (allomsc) |
- |
- |
- |
- |
049 [1] 49 💬 |
154 |
Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded |
- |
- |
- |
- |
090 [1] 90 💬 |
155 |
Allogeneic peripheral blood stem cell |
- |
- |
- |
- |
065 [1] 65 💬 |
156 |
Allogeneic skin-derived abcb5-positive mesenchymal stem cells |
- |
- |
- |
- |
036 [1] 36 💬 |
157 |
Allogeneic stem cell therapy |
- |
- |
- |
- |
096 [1] 96 💬 |
158 |
Allogeneic stem cell transplant |
- |
- |
- |
- |
053 [2] 53, 56 💬 |
159 |
Allogeneic stem cell transplantation |
- |
- |
- |
- |
049 [2] 49, 84 💬 |
160 |
Allogenic eascs 5 milion cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 [1] 96 💬 |
161 |
Allogenic eascs 5 million cells/ml suspension for injection cx601 |
- |
- |
- |
- |
096 [1] 96 💬 |
162 |
Allogenic eascs 5 million cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 [1] 96 💬 |
163 |
Allogenic eascs 5 million/ml suspension for injection. |
- |
- |
- |
- |
096 [1] 96 💬 |
164 |
Allogenic human heterologous liver cells |
- |
- |
- |
- |
251 [1] 251 💬 |
165 |
Allogenic mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
036 [1] 36 💬 |
166 |
Allopregnanolone |
Brexanolone |
[1] D11149 D11149 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
205 [1] 205 💬 |
167 |
Allopurinol |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 [6] 6 , 46, 57, 66, 96, 97 💬 |
168 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 [1] 96 💬 |
169 |
Allopurinol sodium |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 [1] 96 💬 |
170 |
Aln-51547 |
- |
- |
- |
- |
028 [1] 28 💬 |
171 |
Aln-60212 |
- |
- |
- |
- |
079 [1] 79 💬 |
172 |
Aln-60519 |
- |
- |
- |
- |
254 [1] 254 💬 |
173 |
Aln-61444 |
- |
- |
- |
- |
231 [1] 231 💬 |
174 |
Aln-62643 |
- |
- |
- |
- |
062 [1] 62 💬 |
175 |
Aln-65585 |
- |
- |
- |
- |
234 [1] 234 💬 |
176 |
Aln-77412 |
- |
- |
- |
- |
231 [1] 231 💬 |
177 |
Aln-aat |
- |
- |
- |
- |
231 [1] 231 💬 |
178 |
Aln-aat02 |
- |
- |
- |
- |
231 [1] 231 💬 |
179 |
Aln-as1 |
- |
- |
- |
- |
254 [1] 254 💬 |
180 |
Aln-cc5 |
- |
- |
- |
- |
062 [3] 62, 66, 109 💬 |
181 |
Aln-go1 |
- |
- |
- |
- |
234 [1] 234 💬 |
182 |
Aln-pcssc |
Inclisiran |
[1] D11931 D11931 💬 |
PCSK9 [1] PCSK9 💬 |
Cholesterol metabolism [1] Cholesterol metabolism |
079 [1] 79 💬 |
183 |
Aln-ttrsc |
- |
- |
- |
- |
028 [1] 28 💬 |
184 |
Aloasc |
- |
- |
- |
- |
097 [1] 97 💬 |
185 |
Aloe |
Aloe Vera Leaf |
- |
- |
- |
097 [1] 97 💬 |
186 |
Aloe barbadensis miller |
Aloe Vera Leaf |
- |
- |
- |
097 [1] 97 💬 |
187 |
Aloe vera |
Aloe Vera Leaf |
- |
- |
- |
053 [1] 53 💬 |
188 |
Alofisel |
- |
- |
- |
- |
096 [1] 96 💬 |
189 |
Alpha 1-antitrypsin |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [2] 231, 298 💬 |
190 |
Alpha 1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
191 |
Alpha 1-proteinase inhibitor (human) |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
192 |
Alpha beta depletion |
- |
- |
- |
- |
060 [2] 60, 284 💬 |
193 |
Alpha interferon |
- |
- |
- |
- |
056 [1] 56 💬 |
194 |
Alpha lipoic acid |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
013 [1] 13 💬 |
195 |
Alpha-1 antitrypsin (aat) |
- |
- |
- |
- |
231 [1] 231 💬 |
196 |
Alpha-1 antitrypsin (human) |
- |
- |
- |
- |
231 [1] 231 💬 |
197 |
Alpha-1 hc 100 mg |
- |
- |
- |
- |
299 [1] 299 💬 |
198 |
Alpha-1 hc 200 mg |
- |
- |
- |
- |
299 [1] 299 💬 |
199 |
Alpha-1 mp |
- |
- |
- |
- |
231 [1] 231 💬 |
200 |
Alpha-1 proteinase inhibitor (human) |
- |
- |
- |
- |
231 [1] 231 💬 |
201 |
Alpha-1-antitrypsin |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
202 |
Alpha-2c ar antagonist |
- |
- |
- |
- |
051 [1] 51 💬 |
203 |
Alpha-galactosidase a |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
204 |
Alpha-glucosidase |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
205 |
Alpha-lipoic acid |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
002 [2] 2 , 13 💬 |
206 |
Alpha-lipoic acid and l-acetyl carnitine |
Levocarnitine |
[5] D00048 D00048, D00086 D00086, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [1] 5 💬 |
207 |
Alpha-tocopherol |
Tocopherol |
[2] D02331 D02331, D02332 D02332 💬 |
- |
- |
049 [2] 49, 206 💬 |
208 |
Alpha-tocotrienol quinone |
Tocotrienol |
- |
- |
- |
156 [1] 156 💬 |
209 |
Alpha1-antitrypsin |
- |
- |
- |
- |
013 [1] 13 💬 |
210 |
Alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [2] 231, 299 💬 |
211 |
Alpha1-proteinase inhibitor (human) |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [2] 231, 299 💬 |
212 |
Alphanate |
- |
- |
- |
- |
288 [1] 288 💬 |
213 |
Alphanate 1000 i.u. |
- |
- |
- |
- |
288 [1] 288 💬 |
214 |
Alphanate 1500 i.u. |
- |
- |
- |
- |
288 [1] 288 💬 |
215 |
Alphanate sd/ht |
- |
- |
- |
- |
288 [1] 288 💬 |
216 |
Alphanate*inf 1f 1000ui+f 10ml |
- |
- |
- |
- |
288 [1] 288 💬 |
217 |
Alphanate*inf 1f 1500ui+f 10ml |
- |
- |
- |
- |
288 [1] 288 💬 |
218 |
Alphanate*inf 1f 250ui+f 5ml |
- |
- |
- |
- |
288 [1] 288 💬 |
219 |
Alphanate*inf 1f 500ui+f 5ml |
- |
- |
- |
- |
288 [1] 288 💬 |
220 |
Alprazolam |
Alprazolam |
[1] D00225 D00225 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
008 [1] 8 💬 |
221 |
Alprostadil |
Alprostadil |
[2] D00180 D00180, D02705 D02705 💬 |
PTGER1 [1] PTGER1 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 [2] 51, 70 💬 |
222 |
Alrn-5281 0.015 mg/kg |
- |
- |
- |
- |
078 [1] 78 💬 |
223 |
Alrn-5281 0.05 mg/kg |
- |
- |
- |
- |
078 [1] 78 💬 |
224 |
Alrn-5281 0.15 mg/kg |
- |
- |
- |
- |
078 [1] 78 💬 |
225 |
Alth12-1:4 |
- |
- |
- |
- |
097 [1] 97 💬 |
226 |
Alth12-2:4 |
- |
- |
- |
- |
097 [1] 97 💬 |
227 |
Altri farmaci del sistema nervoso |
- |
- |
- |
- |
013 [1] 13 💬 |
228 |
Altropane |
Altropane |
- |
- |
- |
006 [1] 6 💬 |
229 |
Altropane® |
Altropane |
- |
- |
- |
006 [1] 6 💬 |
230 |
Altu-135 |
ALTU-135 |
- |
- |
- |
299 [1] 299 💬 |
231 |
Altu-238 |
- |
- |
- |
- |
078 [1] 78 💬 |
232 |
Altus-135 |
- |
- |
- |
- |
299 [1] 299 💬 |
233 |
Aluminium |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
234 |
Aluminium hydroxide |
Aluminium |
[1] D02416 D02416 💬 |
- |
- |
046 [1] 46 💬 |
235 |
Aluminium phosphate |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
236 |
Alvarez 2 |
- |
- |
- |
- |
037 [1] 37 💬 |
237 |
Alvelestat |
Alvelestat |
- |
- |
- |
231 [1] 231 💬 |
238 |
Alvelestat (mph966) |
Alvelestat |
- |
- |
- |
231 [1] 231 💬 |
239 |
Alvelestat oral tablet - dose 1 |
Alvelestat |
- |
- |
- |
231 [1] 231 💬 |
240 |
Alvelestat oral tablet - dose 2 |
Alvelestat |
- |
- |
- |
231 [1] 231 💬 |
241 |
Alvelestat tosylate |
Alvelestat |
- |
- |
- |
231 [1] 231 💬 |
242 |
Alwextin cream |
- |
- |
- |
- |
036 [1] 36 💬 |
243 |
Alx-0061 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
244 |
Alx-0061 150 mg/ml |
- |
- |
- |
- |
049 [1] 49 💬 |
245 |
Alx-0061 nanobody |
- |
- |
- |
- |
046 [1] 46 💬 |
246 |
Alx-0081 |
- |
- |
- |
- |
064 [1] 64 💬 |
247 |
Alx-009 |
- |
- |
- |
- |
299 [1] 299 💬 |
248 |
Alx-0600 |
- |
- |
- |
- |
096 [1] 96 💬 |
249 |
Alxn1102 |
- |
- |
- |
- |
062 [1] 62 💬 |
250 |
Alxn1103 |
- |
- |
- |
- |
062 [1] 62 💬 |
251 |
Alxn1210 |
- |
- |
- |
- |
002 [5] 2 , 11, 13, 62, 109 💬 |
252 |
Alxn1830 |
- |
- |
- |
- |
035 [2] 35, 61 💬 |
253 |
Alxn1840 |
- |
- |
- |
- |
171 [1] 171 💬 |
254 |
Alxn2040 (ach-0144471) |
- |
- |
- |
- |
062 [2] 62, 222 💬 |
255 |
Alxn2050 |
- |
- |
- |
- |
062 [1] 62 💬 |
256 |
Alzt-op1a (cromolyn) |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
002 [1] 2 💬 |
257 |
Ambrisentan plus spironolactone |
Ambrisentan |
[2] D00443 D00443, D07077 D07077 💬 |
EDNRA [2] EDNRA, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [8] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
258 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
[6] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 [3] OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
259 |
Amniotic fluid allograft |
- |
- |
- |
- |
070 [1] 70 💬 |
260 |
Andrographis paniculata (ethanol extract) |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
097 [1] 97 💬 |
261 |
Anti lymphotoxin alpha |
- |
- |
- |
- |
046 [1] 46 💬 |
262 |
Anti tnf alfa. |
- |
- |
- |
- |
096 [1] 96 💬 |
263 |
Anti tnf alpha agent |
- |
- |
- |
- |
271 [1] 271 💬 |
264 |
Anti tnf alpha therapy |
- |
- |
- |
- |
271 [1] 271 💬 |
265 |
Anti-gm-csf receptor alpha |
- |
- |
- |
- |
046 [1] 46 💬 |
266 |
Anti-integrin alphav mab |
- |
- |
- |
- |
051 [1] 51 💬 |
267 |
Anti-tnf-alpha |
- |
- |
- |
- |
046 [1] 46 💬 |
268 |
Antituberculous therapy along with steroids |
- |
- |
- |
- |
084 [1] 84 💬 |
269 |
Apadamtase alfa |
Apadamtase alfa |
- |
- |
- |
064 [1] 64 💬 |
270 |
Apademtase alfa |
- |
- |
- |
- |
064 [1] 64 💬 |
271 |
Arthroscopy & saline irrigation alone |
- |
- |
- |
- |
046 [1] 46 💬 |
272 |
Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e) |
Ascorbic acid |
[3] D00018 D00018, D02331 D02331, D02332 D02332 💬 |
- |
- |
206 [1] 206 💬 |
273 |
Asfotas alfa |
- |
- |
- |
- |
172 [1] 172 💬 |
274 |
Asfotase alfa |
Asfotase alfa |
[1] D10595 D10595 💬 |
ALPL [1] ALPL 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 [1] 172 💬 |
275 |
Asfotase alfa (alxn1215) |
Asfotase alfa |
[1] D10595 D10595 💬 |
ALPL [1] ALPL 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 [1] 172 💬 |
276 |
Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse |
- |
- |
- |
- |
013 [1] 13 💬 |
277 |
Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy |
- |
- |
- |
- |
065 [1] 65 💬 |
278 |
Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence |
- |
- |
- |
- |
065 [1] 65 💬 |
279 |
Avalglucosidase alfa |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
280 |
Avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
281 |
Avalglucosidase alfa gz402666 |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
282 |
Avalglucosidase alfa(gz402666) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
283 |
Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al |
- |
- |
- |
- |
006 [1] 6 💬 |
284 |
Azathioprine and allopurinol |
Allopurinol |
[3] D00224 D00224, D00238 D00238, D03033 D03033 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
097 [1] 97 💬 |
285 |
Azd3241 alternative titration scheme with formulation 1 or 2 |
- |
- |
- |
- |
006 [1] 6 💬 |
286 |
Baminercept |
Baminercept |
[1] D08866 D08866 💬 |
LTB [1] LTB 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [4] 13, 46, 53, 97 💬 |
287 |
Baminercept alfa |
Baminercept |
[1] D08866 D08866 💬 |
LTB [1] LTB 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [1] 46 💬 |
288 |
Baminercept alfa (bg9924) |
Baminercept |
[1] D08866 D08866 💬 |
LTB [1] LTB 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [1] 46 💬 |
289 |
Behavioral: smoking and alcohol assumption |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 [1] 298 💬 |
290 |
Benzbromaron al |
- |
- |
- |
- |
086 [1] 86 💬 |
291 |
Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala) |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
298 [1] 298 💬 |
292 |
Beta carotene from dunaliella algae |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
096 [1] 96 💬 |
293 |
Beta-alanine |
Alanine |
[2] D00012 D00012, D07561 D07561 💬 |
- |
- |
013 [1] 13 💬 |
294 |
Beta-alanine supplementation |
Alanine |
[2] D00012 D00012, D07561 D07561 💬 |
- |
- |
013 [1] 13 💬 |
295 |
Bgj398 (also known as bbp-831) |
- |
- |
- |
- |
276 [1] 276 💬 |
296 |
Biological: umbilical cord based allogenic mesenchymal stem cell |
- |
- |
- |
- |
113 [1] 113 💬 |
297 |
Botox 100 unites allergan (pr1) |
- |
- |
- |
- |
002 [1] 2 💬 |
298 |
Bovine intesastinal alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
046 [1] 46 💬 |
299 |
Bovine intestinal alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
300 |
Bovine-calf alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
301 |
Bovine-calf alkaline phosphatase biap |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
302 |
Brigatinib |
Brigatinib |
[1] D10866 D10866 💬 |
ALK [1] ALK 💬 |
Non-small cell lung cancer [3] Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer |
034 [1] 34 💬 |
303 |
Brimonidine |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [2] 13, 90 💬 |
304 |
Brimonidine tartrate |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [2] 13, 90 💬 |
305 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
306 |
Bucelipase alfa |
- |
- |
- |
- |
299 [1] 299 💬 |
307 |
Bupivicaine alone |
- |
- |
- |
- |
298 [1] 298 💬 |
308 |
C. albicans |
- |
- |
- |
- |
046 [1] 46 💬 |
309 |
Caffeine alkaloid |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
310 |
Calcium carbonate and alphacalcidol |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
235 [1] 235 💬 |
311 |
Campath, chemo and/or tbi allo sct |
- |
- |
- |
- |
060 [3] 60, 62, 283 💬 |
312 |
Campath-1h (alemtuzumab) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
060 [1] 60 💬 |
313 |
Caplacizumab (alx-0081) |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
314 |
Caplacizumab (an anti-von willebrand factor nanobody alx-0081) |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
315 |
Carmustine, etoposide, cytarabine, and melphalan (beam) |
Carmustine |
[7] D00125 D00125, D00168 D00168, D00254 D00254, D00369 D00369, D03046 D03046, D03637 D03637, D04107 D04107 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
316 |
Cd3/cd19 neg allogeneic bmt |
- |
- |
- |
- |
065 [1] 65 💬 |
317 |
Cd3/cd19 negative allogeneic hematopoietic stem cells |
- |
- |
- |
- |
065 [1] 65 💬 |
318 |
Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in als patients |
- |
- |
- |
- |
002 [1] 2 💬 |
319 |
Cellule cd34+ autologhe trasdotte con idua lv codificante per il cdna dell'alfa-l-iduronidasi |
- |
- |
- |
- |
019 [1] 19 💬 |
320 |
Celulas hepatocitos troncales adultas alogenicas de higado expandidas |
- |
- |
- |
- |
251 [1] 251 💬 |
321 |
Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida |
- |
- |
- |
- |
274 [1] 274 💬 |
322 |
Cerezyme (imiglucerase for injection) |
Imiglucerase |
[2] D02810 D02810, D03020 D03020 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
323 |
Cerezyme® / imiglucerase |
Imiglucerase |
[2] D02810 D02810, D03020 D03020 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
324 |
Cerliponase alfa |
Cerliponase alfa |
[1] D10813 D10813 💬 |
TPP1 [1] TPP1 💬 |
Lysosome [1] Lysosome |
019 [1] 19 💬 |
325 |
Chlorhexidine |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
086 [2] 86, 299 💬 |
326 |
Chlorhexidine gluconate |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
327 |
Chlorhexidine gluconate oral rinse |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
328 |
Ciclesonide |
Ciclesonide |
[1] D01703 D01703 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
329 |
Cipaglucosidase alfa |
- |
- |
- |
- |
256 [1] 256 💬 |
330 |
Clobetasol propionate alone |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
331 |
Combination of minocycline and mtx or mtx alone |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
046 [1] 46 💬 |
332 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
[2] D00088 D00088, D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
333 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
334 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
[21] D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
335 |
Cortef (hydrocortisone) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
336 |
Crema de rapamicina al 1% y excipientes |
- |
- |
- |
- |
157 [1] 157 💬 |
337 |
Csm allogéniques issues de cordons ombilicaux ( mti-pp) |
- |
- |
- |
- |
049 [1] 49 💬 |
338 |
Cultured allogeneic fibroblasts |
- |
- |
- |
- |
036 [1] 36 💬 |
339 |
Cyclo[l-alanyl-l-seryl-l-isoleucyl-l-prolyl-l-prolyl-l-glutaminyl-l-lysyl-l-tyrosyl-d-prolyl-l-prolyl-(2s)-2-aminodecanoyl-l-alpha-glutamyl-l-threonyl] |
- |
- |
- |
- |
299 [1] 299 💬 |
340 |
Cytoreductive regimen followed by a cd34+e- selected allogeneic stem cell transplant |
- |
- |
- |
- |
062 [1] 62 💬 |
341 |
Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas |
- |
- |
- |
- |
274 [1] 274 💬 |
342 |
Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada pei nº 12-088) |
- |
- |
- |
- |
274 [1] 274 💬 |
343 |
D-galactose |
Galactose |
[1] D04291 D04291 💬 |
- |
- |
222 [1] 222 💬 |
344 |
Danicopan (alxn2040) |
Danicopan |
[1] D11641 D11641 💬 |
CFD [1] CFD 💬 |
Complement and coagulation cascades [3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
062 [1] 62 💬 |
345 |
Daratumumab co-formulated with recombinant human hyaluronidase (rhuph20) |
Daratumumab |
[4] D04455 D04455, D04456 D04456, D06604 D06604, D10777 D10777 💬 |
CD38 [1] CD38 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
028 [1] 28 💬 |
346 |
Davunetide (al-108, nap) |
Davunetide |
[1] D09401 D09401 💬 |
- |
- |
005 [3] 5 , 7 , 127 💬 |
347 |
Dehydrated alcohol (absolute alcohol) bp for injection |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 [1] 279 💬 |
348 |
Device: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
060 [1] 60 💬 |
349 |
Device: novel allergen-specific immune signature directed approach to dietary elimination therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
350 |
Diagnostic test: memory alteration test (m@t) |
- |
- |
- |
- |
006 [1] 6 💬 |
351 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
096 [2] 96, 97 💬 |
352 |
Dimebon alone |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
353 |
Dornase alfa |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
053 [2] 53, 299 💬 |
354 |
Dornase alfa (pulmozyme) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
355 |
Dornase alfa [pulmozyme®] |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
356 |
Dornase alpha |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
357 |
Dose of 60 mg/kg alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
358 |
Dose of 60 mg/kg fraction iv-1 alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
359 |
Dual release hydrocortisone (plenadren) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
360 |
Efgartigimod alfa |
Efgartigimod alfa |
[1] D11876 D11876 💬 |
- |
- |
014 [3] 14, 35, 63 💬 |
361 |
Egg albumen powder |
Egg |
- |
- |
- |
096 [1] 96 💬 |
362 |
Elosulfase alfa |
Elosulfase alfa |
[1] D10333 D10333 💬 |
GALNS [1] GALNS 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
363 |
Elosulfase alfa 1 mg/ml intravenous solution [vimizim] |
Elosulfase alfa |
[1] D10333 D10333 💬 |
GALNS [1] GALNS 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
364 |
Enbrel - 50 mg soluzione iniettabile in siringa (vetro da 1 ml) preriempita - uso sottocutaneo 12 siringhe preriempite + 24 tamponi imbevuti di alcol |
- |
- |
- |
- |
046 [1] 46 💬 |
365 |
Enterabio's oral parathyroid hormone (1-34) |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
366 |
Enzyme replacement therapy (agalsidase alpha (replagal®)) |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
367 |
Epoetin alfa |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 [3] 13, 18, 46 💬 |
368 |
Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) |
Bosentan |
[6] D01227 D01227, D02008 D02008, D02229 D02229, D07538 D07538, D08514 D08514, D10135 D10135 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
369 |
Erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [9] 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
370 |
Erythropoietin human recombinant (eporh) |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
006 [1] 6 💬 |
371 |
Estradiol |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [5] 13, 46, 49, 226, 299 💬 |
372 |
Estradiol 2 mg |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 [1] 299 💬 |
373 |
Estradiol hemihydrate |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [1] 13 💬 |
374 |
Ethanol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 [4] 51, 97, 279, 280 💬 |
375 |
Ethanol (96 per cent) |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 [1] 279 💬 |
376 |
Ethanol 96% gel |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 [1] 279 💬 |
377 |
Ethanol 98% solution |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 [1] 279 💬 |
378 |
Ethanol bp |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 [1] 279 💬 |
379 |
Ethanol gel |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 [1] 279 💬 |
380 |
Ethinyl estradiol |
Estradiol |
[9] D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 [3] 46, 49, 299 💬 |
381 |
Etn alone |
- |
- |
- |
- |
046 [1] 46 💬 |
382 |
Expanded allogenic adipose-derived adult stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
383 |
Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 [1] 96 💬 |
384 |
Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eascs) |
- |
- |
- |
- |
096 [1] 96 💬 |
385 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue |
- |
- |
- |
- |
096 [1] 96 💬 |
386 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs |
- |
- |
- |
- |
096 [1] 96 💬 |
387 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 [1] 96 💬 |
388 |
Fdc macitentan/tadalafil |
Macitentan |
[2] D02008 D02008, D10135 D10135 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
389 |
Filgrastim, alemtuzumab |
Alemtuzumab |
[2] D02802 D02802, D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
065 [1] 65 💬 |
390 |
Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse |
- |
- |
- |
- |
011 [1] 11 💬 |
391 |
Fludarabine, melphalan, thiotepa |
Fludarabine |
[4] D00369 D00369, D00583 D00583, D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [1] 65 💬 |
392 |
Fludarabine/ melphalan |
Fludarabine |
[3] D00369 D00369, D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
060 [1] 60 💬 |
393 |
Ga-gcb (velaglucerase alfa) |
Velaglucerase alfa |
[1] D09029 D09029 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
394 |
Galactose |
Galactose |
[1] D04291 D04291 💬 |
- |
- |
171 [2] 171, 222 💬 |
395 |
Gamma-tocopherol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
013 [1] 13 💬 |
396 |
Gene activated human glucocerebrosidase, velaglucerase alfa |
Velaglucerase alfa |
[1] D09029 D09029 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
397 |
Genetic: recombinant adeno-associated virus acid alpha-glucosidase |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
398 |
Givosiran (aln-as1) |
Givosiran |
[1] D11702 D11702 💬 |
ALAS1 [1] ALAS1 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 [1] 254 💬 |
399 |
Glucosidase alfa |
- |
- |
- |
- |
256 [1] 256 💬 |
400 |
Guna-antiinterleukin 1 alfa |
- |
- |
- |
- |
046 [1] 46 💬 |
401 |
Heparin & alkalinized lidocaine bladder instillation |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
402 |
Hla-identical allogeneic mesoangioblasts |
- |
- |
- |
- |
113 [1] 113 💬 |
403 |
Human albumin |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
002 [2] 2 , 96 💬 |
404 |
Human albumin as macroaggregates |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
096 [1] 96 💬 |
405 |
Human albumin solution |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
002 [1] 2 💬 |
406 |
Human allogeneic wj-mscs |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
036 [1] 36 💬 |
407 |
Human anti tnf-alpha monoclonal |
- |
- |
- |
- |
046 [1] 46 💬 |
408 |
Human anti tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 [2] 46, 84 💬 |
409 |
Human anti-tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
410 |
Human leucocyte interferon-alpha |
- |
- |
- |
- |
013 [1] 13 💬 |
411 |
Human recombinant parathyroid hormone |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
412 |
Human recombinant tissue non-specific alkaline phosphatase fusion protein |
Alkaline Phosphatase |
- |
- |
- |
172 [1] 172 💬 |
413 |
Human serum albumin |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
078 [1] 78 💬 |
414 |
Human serum albumin (hsa) fused to recombinant human growth hormone (hgh) |
Albumin human |
[3] D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
415 |
Human serum albumin (hsa) fused to somatropin |
Albumin human |
[3] D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
416 |
Humanized anti-alpha v beta 6 mab |
- |
- |
- |
- |
085 [1] 85 💬 |
417 |
Humanized igg1, kappa anti-serum amyloid a and anti-al amyloid antibody |
- |
- |
- |
- |
028 [1] 28 💬 |
418 |
Hyaluronidase |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 [4] 28, 51, 65, 331 💬 |
419 |
Hyaluronidase injected intradermally |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
051 [1] 51 💬 |
420 |
Hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [9] 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
421 |
Hydrocortisone (solucortef) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
422 |
Hydrocortisone 100mg/ml |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
423 |
Hydrocortisone 10mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
424 |
Hydrocortisone 10mg tablet |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
425 |
Hydrocortisone 10mg tablets |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
426 |
Hydrocortisone 20mg tablets |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
427 |
Hydrocortisone acetate |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
428 |
Hydrocortisone cream |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
429 |
Hydrocortisone cream 1% |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
430 |
Hydrocortisone cream 10mg/g fna fagron |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
431 |
Hydrocortisone hydrogen succinate |
Hydrocortisone |
[2] D00088 D00088, D01442 D01442 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
432 |
Hydrocortisone modified release capsules |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
433 |
Hydrocortisone roussel |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
434 |
Hydrocortisone sodium acetate |
Acetate |
[2] D00088 D00088, D01779 D01779 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
435 |
Hydrocortisone sodium phosphate |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
053 [3] 53, 81, 83 💬 |
436 |
Hydrocortisone sodium succinate |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [3] 81, 83, 97 💬 |
437 |
Hydrocortisone tablet 2.5 mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
438 |
Hydrocortisone takeda, tabletter |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
439 |
Hydroxocobalamin |
Hydroxocobalamin |
[3] D01027 D01027, D02707 D02707, D04929 D04929 💬 |
- |
- |
097 [1] 97 💬 |
440 |
Hydroxocobalamin with butyrate |
Butyric Acid |
[4] D01027 D01027, D02707 D02707, D04929 D04929, D05866 D05866 💬 |
- |
- |
097 [1] 97 💬 |
441 |
Hynrcs-allo inj |
- |
- |
- |
- |
002 [1] 2 💬 |
442 |
Ibandronate+alfacalcidol+calcium |
Alfacalcidol |
[2] D01518 D01518, D08056 D08056 💬 |
FDPS [2] FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [8] Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
049 [1] 49 💬 |
443 |
Ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [6] 13, 46, 65, 113, 271, 299 💬 |
444 |
Ibuprofen 200mg |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
445 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
446 |
Imiglucerase |
Imiglucerase |
[2] D02810 D02810, D03020 D03020 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
447 |
Imiglucerase gz437843 |
Imiglucerase |
[2] D02810 D02810, D03020 D03020 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
448 |
Imiquimod |
Imiquimod |
[1] D02500 D02500 💬 |
TLR7 [1] TLR7 💬 |
Coronavirus disease - COVID-19 [5] Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 [2] 34, 51 💬 |
449 |
Imiquimod 5% cream |
Imiquimod |
[1] D02500 D02500 💬 |
TLR7 [1] TLR7 💬 |
Coronavirus disease - COVID-19 [5] Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 [2] 34, 51 💬 |
450 |
Immediate post operative bioassay of parathyroid hormone |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
451 |
Infliximab (ifx alone) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
452 |
Infusion without ald518' |
- |
- |
- |
- |
046 [1] 46 💬 |
453 |
Injection of allogeneic mesenchymal stem cells |
- |
- |
- |
- |
051 [1] 51 💬 |
454 |
Inn parathyroid hormone (1-84) human |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
455 |
Interferon alfa |
Interferon alfa |
[1] D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 [5] 25, 26, 28, 56, 96 💬 |
456 |
Interferon alfa-2a |
Interferon alfa |
[2] D00745 D00745, D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
056 [1] 56 💬 |
457 |
Interferon alfa-2b |
Interferon alfa |
[2] D02745 D02745, D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 [1] 25 💬 |
458 |
Interferon alpha oral lozenge |
- |
- |
- |
- |
085 [1] 85 💬 |
459 |
Interferon alpha-2a |
Interferon alfa-2a, Recombinant |
[1] D00745 D00745 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
056 [1] 56 💬 |
460 |
Interferon alpha-2b |
Interferon alfa-2b |
[1] D02745 D02745 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
034 [1] 34 💬 |
461 |
Interferon beta-1a (rebif®) alone |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
462 |
Interferon-alpha |
- |
- |
- |
- |
331 [1] 331 💬 |
463 |
Interferon-alpha lozenges |
- |
- |
- |
- |
085 [1] 85 💬 |
464 |
Interferon-alpha2a |
- |
- |
- |
- |
056 [1] 56 💬 |
465 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 [2] 96, 97 💬 |
466 |
Intrathecal recombinant human alpha iduronidase |
- |
- |
- |
- |
019 [1] 19 💬 |
467 |
Irt laronidase |
Laronidase |
[1] D04670 D04670 💬 |
IDUA [1] IDUA 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
468 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
469 |
Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
470 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
471 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
472 |
Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
473 |
L-3-(3,4-dihydroxyphenyl)alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [1] 6 💬 |
474 |
L-alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
299 [1] 299 💬 |
475 |
Laronidase |
Laronidase |
[1] D04670 D04670 💬 |
IDUA [1] IDUA 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [2] 19, 256 💬 |
476 |
Laronidase ert |
Laronidase |
[1] D04670 D04670 💬 |
IDUA [1] IDUA 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
477 |
Lentivirus alpha-gal a transduced stem cells |
- |
- |
- |
- |
019 [1] 19 💬 |
478 |
Loestrin (norethindrone acetate and ethinyl estradiol) |
Acetate |
[11] D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [3] ESR1, ESR2, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 [1] 299 💬 |
479 |
Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) |
Acetate |
[11] D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [3] ESR1, ESR2, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 [2] 46, 49 💬 |
480 |
Long term follow up in all patients who received sar422459 in previous study tdu13583 |
- |
- |
- |
- |
301 [1] 301 💬 |
481 |
Lovastatin |
Lovastatin |
[1] D00359 D00359 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬 |
482 |
Lovastatin 60 mg |
Lovastatin |
[1] D00359 D00359 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
034 [1] 34 💬 |
483 |
Lovastatin ™ |
Lovastatin |
[1] D00359 D00359 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
034 [1] 34 💬 |
484 |
Lovastatin, then minocycline/lovastatin |
Lovastatin |
[3] D00359 D00359, D00850 D00850, D05045 D05045 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
206 [1] 206 💬 |
485 |
Low-dose aldesleukin (proleukin®) |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [1] 49 💬 |
486 |
Magnesium gluconate |
Magnesium |
[1] D04835 D04835 💬 |
- |
- |
296 [2] 296, 297 💬 |
487 |
Melphalan |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
011 [15] 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
488 |
Melphalan fulfenamide hydrochloride |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
028 [1] 28 💬 |
489 |
Melphalan hydrochloride |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
060 [1] 60 💬 |
490 |
Melphalan, thalidomide and dexamethasone |
Dexamethasone |
[11] D00292 D00292, D00369 D00369, D00754 D00754, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
491 |
Melphalan-flufenamide (melflufen) |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
028 [1] 28 💬 |
492 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
[2] D00377 D00377, D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
493 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
[2] D00088 D00088, D00377 D00377 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
494 |
Methotrexate plus enbrel or enbrel alone |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
495 |
Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al |
Metoclopramide |
[3] D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 [1] 51 💬 |
496 |
Minocycline, then minocycline/lovastatin |
Lovastatin |
[3] D00359 D00359, D00850 D00850, D05045 D05045 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
206 [1] 206 💬 |
497 |
Moss-agal (recombinant human alpha-galactosidase a produced in moss) |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
498 |
Myozyme® (alglucosidase alfa) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
499 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
[2] D02147 D02147, D02212 D02212 💬 |
ADRB2 [6] ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes [17] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
500 |
Neogaa or avalglucosidase alfa |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
501 |
Nitazoxanide |
Nitazoxanide |
[1] D02486 D02486 💬 |
- |
- |
096 [2] 96, 97 💬 |
502 |
Nitazoxanide 500mg oral tablet |
Nitazoxanide |
[1] D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
503 |
Nle4-d-phe7-alpha-msh |
- |
- |
- |
- |
254 [1] 254 💬 |
504 |
Obyoctocog alfa |
- |
- |
- |
- |
288 [1] 288 💬 |
505 |
Octocog alfa |
Antihemophilic factor, human recombinant |
[1] D02958 D02958 💬 |
- |
- |
288 [1] 288 💬 |
506 |
Oligog-cf5/20, alginate oligosaccharide (g-block) fragment |
Alginic acid |
[1] D02324 D02324 💬 |
- |
- |
299 [1] 299 💬 |
507 |
Oligomer of sodium alginate |
Alginic acid |
[1] D02324 D02324 💬 |
- |
- |
299 [1] 299 💬 |
508 |
Olipudase alfa |
Olipudase alfa |
[1] D10820 D10820 💬 |
SMPD1 [1] SMPD1 💬 |
Lysosome [5] Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway |
019 [1] 19 💬 |
509 |
Olipudase alfa (rhasm) |
Olipudase alfa |
[1] D10820 D10820 💬 |
SMPD1 [1] SMPD1 💬 |
Lysosome [5] Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway |
019 [1] 19 💬 |
510 |
One alpha |
- |
- |
- |
- |
050 [1] 50 💬 |
511 |
One alpha drops |
- |
- |
- |
- |
050 [1] 50 💬 |
512 |
One-alpha |
- |
- |
- |
- |
050 [1] 50 💬 |
513 |
One-alpha drops |
- |
- |
- |
- |
050 [1] 50 💬 |
514 |
Oral all-trans retinoic acid (atra) |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
094 [1] 94 💬 |
515 |
Ornithine alpha ketoglutarate |
Ornithine |
[1] D08302 D08302 💬 |
- |
- |
245 [1] 245 💬 |
516 |
Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg |
Estradiol |
[10] D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D05209 D05209 💬 |
ESR1 [3] ESR1, ESR2, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 [1] 299 💬 |
517 |
Other: continuation of dornase alfa (dnase) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
518 |
Other: discontinuation of dornase alfa (dnase) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
519 |
Other: functional involvement of identified epigenetic alterations |
- |
- |
- |
- |
102 [1] 102 💬 |
520 |
Other: hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
521 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
[6] D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
522 |
Other: iv steroids combination alone |
- |
- |
- |
- |
041 [1] 41 💬 |
523 |
Other: natural herbs of coconut, aloe vera, and pepperint |
Aloe Vera Leaf |
- |
- |
- |
053 [1] 53 💬 |
524 |
Other: other: symptomatic treatment of als |
- |
- |
- |
- |
002 [1] 2 💬 |
525 |
Other: physalis angulata ethanol extract |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 [1] 51 💬 |
526 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
527 |
Other: withdrawal from alpha1 antitrypsin replacement therapy |
- |
- |
- |
- |
231 [1] 231 💬 |
528 |
Parathyroid hormone |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 [2] 70, 235 💬 |
529 |
Parathyroid hormone (1-84) human recombinant |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
530 |
Parathyroid hormone (rdna) |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
531 |
Peg-interferon alpha-2b |
Interferon alfa-2b |
[1] D02745 D02745 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
034 [1] 34 💬 |
532 |
Pegunigalsidase alfa |
Pegunigalsidase alfa |
[1] D11685 D11685 💬 |
- |
- |
019 [1] 19 💬 |
533 |
Pegunigalsidase alpha |
- |
- |
- |
- |
019 [1] 19 💬 |
534 |
Pegylated interferon alfa |
Interferon alfa |
[1] D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
096 [1] 96 💬 |
535 |
Pegylated interferon alpha2b |
- |
- |
- |
- |
227 [1] 227 💬 |
536 |
Pegylated recombinant human hyaluronidase ph20 |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 [1] 28 💬 |
537 |
Pemirolast |
Pemirolast |
[2] D01088 D01088, D07476 D07476 💬 |
- |
- |
113 [1] 113 💬 |
538 |
Pertussis filamentous haemagglutinin adsorbed on aluminium hydroxide |
Aluminium |
[1] D02416 D02416 💬 |
- |
- |
046 [1] 46 💬 |
539 |
Pertussis pertactin adsorbed on aluminium hydroxide |
Aluminium |
[1] D02416 D02416 💬 |
- |
- |
046 [1] 46 💬 |
540 |
Pertussis toxoid adsorbed on aluminium hydroxide |
Aluminium |
[1] D02416 D02416 💬 |
- |
- |
046 [1] 46 💬 |
541 |
Phenytoin |
Phenytoin |
[2] D00512 D00512, D02103 D02103 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
542 |
Pioglitazone and tretinoin |
Pioglitazone |
[3] D00094 D00094, D00945 D00945, D08378 D08378 💬 |
PML [4] PML, PPARG, RARA, RARB 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Longevity regulating pathway, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 [1] 2 💬 |
543 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
544 |
Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) |
Diethyl ether |
[2] D01772 D01772, D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
545 |
Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [1] 6 💬 |
546 |
Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin) |
- |
- |
- |
- |
006 [1] 6 💬 |
547 |
Prednisone 0,5 mg/kg orally on alternate days |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
548 |
Prednisone alone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [2] 11, 66 💬 |
549 |
Procedure: alcohol wipes vs. no alcohol wipes |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 [1] 13 💬 |
550 |
Procedure: allo bmt |
- |
- |
- |
- |
065 [1] 65 💬 |
551 |
Procedure: allogeneic bone marrow transplantation |
- |
- |
- |
- |
060 [6] 60, 65, 96, 164, 284, 285 💬 |
552 |
Procedure: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [8] 28, 51, 60, 62, 65, 164, 284, 285 💬 |
553 |
Procedure: allogeneic hsc |
- |
- |
- |
- |
065 [1] 65 💬 |
554 |
Procedure: allogeneic hsct |
- |
- |
- |
- |
065 [1] 65 💬 |
555 |
Procedure: allogeneic stem cell transplant |
- |
- |
- |
- |
060 [1] 60 💬 |
556 |
Procedure: allogeneic stem cell transplantation |
- |
- |
- |
- |
019 [3] 19, 20, 62 💬 |
557 |
Procedure: allogenic stem cell transplantation |
- |
- |
- |
- |
060 [1] 60 💬 |
558 |
Procedure: allograft |
- |
- |
- |
- |
070 [1] 70 💬 |
559 |
Procedure: hydrocortisone withdrawal |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
560 |
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [6] 28, 51, 60, 62, 65, 285 💬 |
561 |
Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
051 [1] 51 💬 |
562 |
Procedure: reduced intensity allogeneic transplant |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
563 |
Procedure: repair of cdh w/alloderm |
- |
- |
- |
- |
294 [1] 294 💬 |
564 |
Procedure: trans-right ventricular alcohol septal ablation (trvasa) |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
058 [1] 58 💬 |
565 |
Propylene glycol-free melphalan hydrochloride |
Melphalan |
[2] D00078 D00078, D00369 D00369 💬 |
- |
- |
028 [1] 28 💬 |
566 |
Prx-102 (pegunigalsidase alfa) |
Pegunigalsidase alfa |
[1] D11685 D11685 💬 |
- |
- |
019 [1] 19 💬 |
567 |
Prx002, elt2, anti-alpha-synuclein monoclonal antibody |
- |
- |
- |
- |
006 [1] 6 💬 |
568 |
Pulmozyme (dornase alfa) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
569 |
Pulmozyme (dornase alpha) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
570 |
R-salbutamol |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
571 |
R-salbutamol sulphate |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
572 |
Ramipril |
Ramipril |
[1] D00421 D00421 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 [7] 46, 49, 66, 67, 113, 218, 257 💬 |
573 |
Rapamicina tópica al 1% y excipiente |
- |
- |
- |
- |
157 [1] 157 💬 |
574 |
Rcombinant human parathyroid hormone [rhpth(1-84)] |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
575 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
576 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
577 |
Recombinant adeno-associated viral vector expressing the human alpha-1-antitrypsin gene |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
578 |
Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a |
- |
- |
- |
- |
019 [1] 19 💬 |
579 |
Recombinant alpha-galactosidase a |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
580 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
581 |
Recombinant human acid alfa-glucosidase |
- |
- |
- |
- |
256 [1] 256 💬 |
582 |
Recombinant human acid alfa-glucosidase (atb200) |
- |
- |
- |
- |
256 [1] 256 💬 |
583 |
Recombinant human acid alfa-glucosidase (rhgaa) |
- |
- |
- |
- |
256 [1] 256 💬 |
584 |
Recombinant human acid alpha-glucosidase (rhgaa) |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
585 |
Recombinant human alpha b-crystallin |
- |
- |
- |
- |
013 [1] 13 💬 |
586 |
Recombinant human alpha-galactosidase |
- |
- |
- |
- |
019 [1] 19 💬 |
587 |
Recombinant human alpha-galactosidase abbreviated as r-h-alpha-gal |
- |
- |
- |
- |
019 [1] 19 💬 |
588 |
Recombinant human alpha-mannosidase |
- |
- |
- |
- |
019 [1] 19 💬 |
589 |
Recombinant human alpha-n-acetylglucosaminidase (rhnaglu) |
- |
- |
- |
- |
019 [1] 19 💬 |
590 |
Recombinant human erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 [1] 13 💬 |
591 |
Recombinant human erythropoietin(rhepo) |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [1] 2 💬 |
592 |
Recombinant human hyaluronidase |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 [2] 28, 65 💬 |
593 |
Recombinant human hyaluronidase (rhuph20) |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
065 [1] 65 💬 |
594 |
Recombinant human hyaluronidase (rhuph20)+ immune globulin intravenous (igiv) |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
065 [1] 65 💬 |
595 |
Recombinant human hyaluronidase + immune globulin intravenous |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
065 [1] 65 💬 |
596 |
Recombinant human hyaluronidase ph20 |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 [1] 28 💬 |
597 |
Recombinant human lysosomal alpha-mannosidase |
- |
- |
- |
- |
019 [1] 19 💬 |
598 |
Recombinant human parathyroid hormone (1-84) |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
599 |
Recombinant human parathyroid hormone [rhpth(1-84)] |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
600 |
Recombinant human serum albumin (hsa) fused to human growth hormone (hgh) |
Albumin human |
[3] D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
601 |
Recombinant humanized anti-alpha 4 integrin antibody |
- |
- |
- |
- |
013 [1] 13 💬 |
602 |
Recombinant interferon alfa |
Interferon alfa |
[1] D03305 D03305 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
026 [2] 26, 28 💬 |
603 |
Replagal (agalsidase alfa) |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
604 |
Replagal agalsidase alfa |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
605 |
Reveglucosidase alfa |
- |
- |
- |
- |
256 [1] 256 💬 |
606 |
Reveglucosidase alpha |
- |
- |
- |
- |
256 [1] 256 💬 |
607 |
Rhgaa, acid alpha glucosidase |
- |
- |
- |
- |
256 [1] 256 💬 |
608 |
Rhidu (recombinant human-alpha-l-iduronidase) |
- |
- |
- |
- |
019 [1] 19 💬 |
609 |
Riluzolo teva - 50 mg compresse rivestite con film 90 compresse in blister al/pvc |
- |
- |
- |
- |
114 [1] 114 💬 |
610 |
Rituximab or rituximab hyaluronidase human |
Hyaluronidase |
[4] D02994 D02994, D04455 D04455, D04456 D04456, D06604 D06604 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
331 [1] 331 💬 |
611 |
Rurioctocog alfa pegol |
Rurioctocog alfa pegol |
[1] D10760 D10760 💬 |
- |
- |
288 [1] 288 💬 |
612 |
S.c. injections of bovine intestinal alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 [1] 46 💬 |
613 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
614 |
Salbutamol 4mg tablet |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
615 |
Salbutamol sulfate |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
111 [1] 111 💬 |
616 |
Salbutamol sulfate ph. eur. |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
617 |
Salbutamol wzf 4 mg |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
618 |
Sebelipasa alfa |
Sebelipase alfa |
[1] D10377 D10377 💬 |
LIPA [1] LIPA 💬 |
Cholesterol metabolism [3] Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 [1] 19 💬 |
619 |
Sebelipase alfa |
Sebelipase alfa |
[1] D10377 D10377 💬 |
LIPA [1] LIPA 💬 |
Cholesterol metabolism [3] Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 [1] 19 💬 |
620 |
Sebelipase alfa (sbc-102) |
Sebelipase alfa |
[1] D10377 D10377 💬 |
LIPA [1] LIPA 💬 |
Cholesterol metabolism [3] Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 [1] 19 💬 |
621 |
Sebelipase alfa 0.35 mg/kg |
Sebelipase alfa |
[1] D10377 D10377 💬 |
LIPA [1] LIPA 💬 |
Cholesterol metabolism [3] Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 [1] 19 💬 |
622 |
Sebelipase alfa 1 mg/kg |
Sebelipase alfa |
[1] D10377 D10377 💬 |
LIPA [1] LIPA 💬 |
Cholesterol metabolism [3] Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 [1] 19 💬 |
623 |
Sebelipase alfa 3 mg/kg |
Sebelipase alfa |
[1] D10377 D10377 💬 |
LIPA [1] LIPA 💬 |
Cholesterol metabolism [3] Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 [1] 19 💬 |
624 |
Serum albumin |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
078 [1] 78 💬 |
625 |
Serum albumine 5% |
- |
- |
- |
- |
096 [1] 96 💬 |
626 |
Simvastatin alternova |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
627 |
Sitaxsentan alone |
Sitaxentan |
[1] D07171 D07171 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
628 |
Sodium alginate |
Alginic acid |
[1] D02324 D02324 💬 |
- |
- |
299 [1] 299 💬 |
629 |
Solu-cortef (hydrocortisone) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
630 |
Spironolactone |
Spironolactone |
[1] D00443 D00443 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
058 [7] 58, 67, 86, 113, 210, 218, 225 💬 |
631 |
Spironolactone (drug) |
Spironolactone |
[1] D00443 D00443 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
210 [1] 210 💬 |
632 |
Spironolactone and conivaptan |
Conivaptan |
[3] D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A [3] AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
633 |
Spironolactone captopril carvedilol |
Captopril |
[4] D00251 D00251, D00255 D00255, D00443 D00443, D03415 D03415 💬 |
ACE [7] ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 |
AMPK signaling pathway [18] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
634 |
Subcutaneous hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
635 |
Subcutaneous hydrocortisone 10mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
636 |
Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin) |
Aldosterone |
[3] D00150 D00150, D02014 D02014, D10528 D10528 💬 |
AGTR1 [3] AGTR1, AGTR2, NR3C2 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
637 |
Synthetic human parathyroid hormone 1-34 |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
638 |
Tadalafil |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [7] 6 , 51, 75, 84, 86, 113, 210 💬 |
639 |
Tadalafil 20 mg |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 [1] 113 💬 |
640 |
Tadalafil 20 mg film-coated tablets |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
641 |
Tadalafil 40 mg |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
642 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
[2] D02008 D02008, D07077 D07077 💬 |
EDNRA [2] EDNRA, PDE5A 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
643 |
Tadalafil and sildenafil |
Sildenafil |
[3] D02008 D02008, D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 [1] 113 💬 |
644 |
Tadalafil citrate |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
210 [1] 210 💬 |
645 |
Tadalafil oral suspension |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
646 |
Tadalafil, placebo |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
647 |
Tadalafil- tablet or oral suspension |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
648 |
Tadekinig alfa |
Tadekinig alfa |
- |
- |
- |
065 [1] 65 💬 |
649 |
Taliglucerase alfa |
Taliglucerase alfa |
[1] D09675 D09675 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
650 |
Taliglucerase alfa - recombinant human glucocerebrosidase |
Taliglucerase alfa |
[1] D09675 D09675 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
651 |
Tcr alfa beta t cell depletion |
- |
- |
- |
- |
065 [1] 65 💬 |
652 |
Teduglutide (alx-0600) |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
653 |
Tenofovir alafenamide |
Tenofovir |
[2] D06074 D06074, D10428 D10428 💬 |
- |
- |
002 [1] 2 💬 |
654 |
Tenofovir alafenamide (taf) |
Tenofovir |
[2] D06074 D06074, D10428 D10428 💬 |
- |
- |
002 [1] 2 💬 |
655 |
Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34) |
Parathyroid hormone |
[2] D05364 D05364, D06078 D06078 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 [1] 70 💬 |
656 |
Tetanus + pnemococcal vaccines alone |
- |
- |
- |
- |
046 [1] 46 💬 |
657 |
Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
658 |
Therapeutic allogeneic lymphocytes |
- |
- |
- |
- |
060 [3] 60, 65, 285 💬 |
659 |
Thrombomodulin alfa |
Thrombomodulin Alfa |
[1] D06410 D06410 💬 |
F2 [1] F2 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
085 [1] 85 💬 |
660 |
Timolol alcon 0.5% collyre |
Timolol |
[3] D00378 D00378, D00603 D00603, D08600 D08600 💬 |
ADRB1 [2] ADRB1, ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
661 |
Tnf alpha |
- |
- |
- |
- |
271 [1] 271 💬 |
662 |
Tnf alpha blockers |
- |
- |
- |
- |
046 [1] 46 💬 |
663 |
Tnf alpha inhibitors |
- |
- |
- |
- |
046 [1] 46 💬 |
664 |
Tnf-alpha antagonist and other biotherapy |
- |
- |
- |
- |
046 [1] 46 💬 |
665 |
Tnf-alpha antagonists |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
666 |
Tnf-alpha inhibitor |
- |
- |
- |
- |
046 [1] 46 💬 |
667 |
Tobi podhaler - 28 mg polvere per inalazione capsula rigida uso inalatorio blister(alu/alu) 56 capsule + 1 inalatore |
- |
- |
- |
- |
299 [1] 299 💬 |
668 |
Tocopherol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
013 [5] 13, 49, 206, 257, 298 💬 |
669 |
Tocopherol (vit e) |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
257 [1] 257 💬 |
670 |
Tocopherol acetate |
Acetate |
[1] D02332 D02332 💬 |
- |
- |
049 [1] 49 💬 |
671 |
Transplant conditioning with mobilization and alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
065 [1] 65 💬 |
672 |
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan |
Alemtuzumab |
[5] D00369 D00369, D00583 D00583, D01907 D01907, D02802 D02802, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [2] 65, 164 💬 |
673 |
Treatment algorithm a |
- |
- |
- |
- |
097 [1] 97 💬 |
674 |
Treatment algorithm b |
- |
- |
- |
- |
097 [1] 97 💬 |
675 |
Treatment algorithm c |
- |
- |
- |
- |
097 [1] 97 💬 |
676 |
Tretinoin |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 [2] 2 , 75 💬 |
677 |
Tretinoin and pioglitazone hcl |
Pioglitazone |
[3] D00094 D00094, D00945 D00945, D08378 D08378 💬 |
PML [4] PML, PPARG, RARA, RARB 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Longevity regulating pathway, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 [1] 2 💬 |
678 |
Un-alpha-r |
- |
- |
- |
- |
235 [1] 235 💬 |
679 |
Un-alpha-r 0.25µg |
- |
- |
- |
- |
235 [1] 235 💬 |
680 |
Usan: sebelipasa alfa |
Sebelipase alfa |
[1] D10377 D10377 💬 |
LIPA [1] LIPA 💬 |
Cholesterol metabolism [3] Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 [1] 19 💬 |
681 |
Usan: sebelipase alpha |
- |
- |
- |
- |
019 [1] 19 💬 |
682 |
Velaglucerase alfa |
Velaglucerase alfa |
[1] D09029 D09029 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
683 |
Velaglucerase alfa (vpriv) |
Velaglucerase alfa |
[1] D09029 D09029 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
684 |
Velaglucerasi alfa |
- |
- |
- |
- |
019 [1] 19 💬 |
685 |
Velmanase alfa |
Velmanase alfa |
[1] D11024 D11024 💬 |
MAN2B1 [1] MAN2B1 💬 |
Lysosome [2] Lysosome, Other glycan degradation |
019 [1] 19 💬 |
686 |
Velmanase alfa (e.g. lamazym) |
Velmanase alfa |
[1] D11024 D11024 💬 |
MAN2B1 [1] MAN2B1 💬 |
Lysosome [2] Lysosome, Other glycan degradation |
019 [1] 19 💬 |
687 |
Vimizim® (elosulfase alfa) |
Elosulfase alfa |
[1] D10333 D10333 💬 |
GALNS [1] GALNS 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
688 |
Viusid/alzer |
- |
- |
- |
- |
006 [1] 6 💬 |
689 |
Voltarol sr (generics also available in the eu) |
- |
- |
- |
- |
046 [1] 46 💬 |
690 |
Vonicog alfa |
Vonicog Alfa |
[1] D08681 D08681 💬 |
- |
- |
288 [1] 288 💬 |
691 |
Xcel-mc-alpha |
- |
- |
- |
- |
013 [1] 13 💬 |
692 |
Zuglimet - 500 mg compresse rivestite con film 30 compresse in blister pvc/al |
- |
- |
- |
- |
067 [1] 67 💬 |